Hardin Memorial Health has joined the University of Kentucky Markey Cancer Center Research Network, allowing patients across Central Kentucky to participate in clinical trials in Elizabethtown, officials announced Friday.
Physicians and other leaders from Hardin Memorial Health and the UK Markey Cancer Center, Kentucky’s only National Cancer Institute designated center, celebrated the new partnership at the HMH Cancer Care Center in Elizabethtown. In recognition of this higher level of patient care, cancer patients at the center attended the event and hung holiday ornaments in awareness of some of the area’s most prevalent cancers.
As a member of the UK Markey Cancer Center Research Network, HMH will be able to conduct Markey-led and some major National Center Institute-led clinical trials because of Markey’s position as an National Cancer Institute-designated cancer center.
Clinical trials are key to developing new methods to prevent, detect and treat cancer, and most treatments used today are the results of previous clinical studies. These may include studies in which patients who need cancer treatment receive their therapy under the observation of specially trained cancer doctors and staff. Patients who volunteer for cancer treatment studies will either receive standard therapy or a new treatment that represents the researchers’ best new ideas for how to improve cancer care.
Additionally, the HMH Cancer Care Center has offered clinical trials in Elizabethtown for about two years through a partnership with the Baptist Health Cancer Research Network. Clinical trials through Baptist Health Cancer Research Network may focus on breast cancer, brain cancer, lung, colon, cervical, melanoma and others.
You must be logged in to post a comment.